Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Efficacy and Safety of Thymosin Alpha 1 for Sepsis: a Multicenter , Double-Blinded, Randomized and Controlled Clinical Trial

NCT02867267 is registered in ClinicalTrials.gov with Sun Yat-sen University as lead sponsor.

NCT NCT02867267
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02867267 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Efficacy and Safety of Thymosin Alpha 1 for Sepsis: a Multicenter , Double-Blinded, Randomized and Controlled Clinical Trial
Lead sponsor
Sun Yat-sen University
Phase
Phase 3
Overall status
Completed
Start date
September 6, 2016
Completion date
March 23, 2021
Enrollment
1,106 (actual)
Sites
22

Conditions

As the registry lists them; a condition with its own page is linked.

sepsis